Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - OURPETS COFinancial_Report.xls
EX-31.2 - EXHIBIT 31.2 - OURPETS COv326427_ex31-2.htm
EX-32.1 - EXHIBIT 32.1 - OURPETS COv326427_ex32-1.htm
EX-32.2 - EXHIBIT 32.2 - OURPETS COv326427_ex32-2.htm
EX-31.1 - EXHIBIT 31.1 - OURPETS COv326427_ex31-1.htm
EX-10.70 - EXHIBIT 10.70 - OURPETS COv326427_ex10-70.htm
EX-10.69 - EXHIBIT 10.69 - OURPETS COv326427_ex10-69.htm
EX-10.68 - EXHIBIT 10.68 - OURPETS COv326427_ex10-68.htm
10-Q - FORM 10-Q - OURPETS COv326427_10q.htm

 

Exhibit 11

 

OURPET'S COMPANY AND SUBSIDIARIES

 

STATEMENT OF COMPUTATION OF NET INCOME PER SHARE

 

   For the Three Months Ended   For the Nine Months Ended 
   September 30,   September 30, 
   2012   2011   2012   2011 
                 
Net income (loss)  $(130,097)  $(285,055)  $(39,915)  $273,329 
                     
Preferred Stock dividend requirements   (20,350)   (23,068)   (60,114)   (68,451)
                     
Net income (loss) attributable to common stockholders  $(150,447)  $(308,123)  $(100,029)  $204,878 
                     
Weighted average number of common shares outstanding   15,811,250    15,737,314    15,809,771    15,733,380 
                     
Preferred Stock Common Share Equivalents   -    -    -    - 
                     
Dilutive Stock Options outstanding for the Period   -    688,798    -    761,825 
                     
Dilutive Warrants outstanding for the Period   -    1,188,496    -    1,480,825 
                     
Weighted average number of common and equivalent shares outstanding   15,811,250    17,614,608    15,809,771    17,976,030 
                     
Net income (loss) per common share  $(0.01)  $(0.02)  $(0.01)  $0.01